- Adeza Biomedical
- Anesta
- Aventis
- Barr Laboratories
- Bayer HealthCare
- Boehringer-Ingelheim
- CommonHealth
- Covance
- Cytyc (now Hologic)
- DebioPharma
- DOR BioPharma
- La Jolla Pharmaceuticals
- MGI
- Otsuka Pharmaceuticals
- Pfizer
- Quintiles
- sanofi-aventis
- Solvay Pharmaceuticals
- Takeda Pharmaceuticals
- TAP Pharmaceuticals
- Targanta Therapeutics
- about us
- Our Team
- News
- what we do
- our services
- our success
- Clients
- Therapeutic Areas
- Case Studies
-
- contact us
- FDA Advisory Committee Process
- Pete Taft interviews Douglas Greene, Senior Vice President and Senior Scientific Advisor for Sanofi-Aventis about the changing landscape of FDA Advisory Committee hearings.
